Cancer Treatment and Research Communications Volume 30 to 33

Announcement: Cancer Treatment and Research Communications – Open Access Journal

Cancer Treatment and Research Communications is an esteemed international, open-access journal committed to advancing comprehensive oncology research. Beginning in January 2020, authors publishing in Cancer Treatment and Research Communications will enjoy the benefits of open access publishing, ensuring their work is immediately, permanently, and freely accessible to a global readership. Authors will have the flexibility to choose from a range of licensing options and will retain copyright to their published work.

Focus and Scope:

Cancer Treatment and Research Communications covers a wide spectrum of oncology-related topics, encompassing basic, translational, and clinical research. The journal serves as a platform for disseminating knowledge on the detection, diagnosis, prevention, and treatment of cancer. Key areas of interest include:

1. Basic, Translational, and Clinical Research: Exploration of cancer detection, diagnosis, prevention, and treatment strategies across different tumor types.
2. Cancer Biology: Studies on the biological underpinnings of cancer, including molecular carcinogenesis, cancer genetics, and genomics.
3. Molecular and Cellular Oncology: Research on molecular and cellular mechanisms involved in cancer development and progression.
4. Cancer Stem Cells: Investigations into cancer stem cells and their roles in tumor growth and treatment resistance.
5. Systems Biology: Studies applying systems biology approaches to understand cancer complexity.
6. Immuno-Oncology: Research on the interactions between the immune system and cancer, with a focus on immunotherapeutic approaches.
7. Chemoprevention Strategies: Strategies for preventing cancer development, including the use of chemopreventive agents.
8. Gene and Antisense Therapy: Developments in gene therapy and antisense therapy for cancer treatment.
9. Pathology of Cancer: Insights into cancer pathology, including prognostic and predictive markers.
10. Drug Sensitivity and Resistance: Research on drug sensitivity and resistance mechanisms in cancer.
11. Novel Treatment Strategies: Exploration of innovative treatment approaches to improve patient care.
12. Clinical Studies: Emphasis on prospective early-phase clinical trials in oncology.

Journal Mission:

The mission of Cancer Treatment and Research Communications is to serve as the premier source of relevant information in oncology. The journal aims to promote excellence in research and facilitate the timely translation of scientific discoveries into clinical practice and patient care. Cancer Treatment and Research Communications offers a platform for nurturing and developing future generations of oncology scientists.

Peer-Reviewed Article Types:

The journal welcomes a variety of article types, including:

• Original Reports: Original research articles reporting significant findings in oncology.
• Reviews: Comprehensive reviews of specific oncology topics or recent advancements.
• Editorials: Expert insights and perspectives on key issues in oncology.

Please note that Cancer Treatment and Research Communications does not consider Case Reports or articles related to Cancer Policy.

All content is published exclusively in the English language, promoting international accessibility and collaboration. The move to open access ensures that the research published in the journal reaches a global audience and contributes to the advancement of cancer science and patient care.

Volume 30: 2022

Volume 31: 2022

Volume 32: 2022

Volume 33: 2022